Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Na Yao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8550-0519; OpenAlex author ID A5020197913. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. CEMIP2 sensitizes PDAC to chemotherapy through extracellular matrix remodeling by hyaluronan degradation. Co-author DOI 10.1016/j.canlet.2025.217898↗
  2. Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multice… Co-author DOI 10.7150/thno.84978↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yizhi Cao · 2 shared papers, 2023–2025 · strength 0.40
  2. Lingxi Jiang · 2 shared papers, 2023–2025 · strength 0.40
  3. Baiyong Shen · 2 shared papers, 2023–2025 · strength 0.40
  4. Jiejie Qin · 1 shared paper, 2025 · strength 0.26
  5. Longjun Zang · 1 shared paper, 2023 · strength 0.14
  6. Shuyu Zhai · 1 shared paper, 2023 · strength 0.14
  7. Shulin Zhao · 1 shared paper, 2023 · strength 0.14
  8. Haoyu Tang · 1 shared paper, 2023 · strength 0.14
  9. Dongjie Chen · 1 shared paper, 2023 · strength 0.14
  10. Weishen Wang · 1 shared paper, 2023 · strength 0.14
  11. Yongsheng Jiang · 1 shared paper, 2023 · strength 0.14
  12. Chenghong Peng · 1 shared paper, 2023 · strength 0.14
  13. Xiaxing Deng · 1 shared paper, 2023 · strength 0.14
  14. Chenlei Wen · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.